RXRX Earnings History
Recursion Pharmaceuticals, Inc. has beat EPS estimates in 2 of the last 6 quarters.
| Date | EPS Est. | EPS Actual | Surprise | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| May 4, 2026 | -0.27 | N/A | N/A | $17.5M | N/A |
| Feb 25, 2026 | -0.28 | -0.21 | N/A | $24.5M | $35.4M |
| Nov 5, 2025 | -0.38 | -0.36 | N/A | $24.6M | $5.2M |
| Aug 5, 2025 | -0.35 | -0.41 | N/A | $19.9M | $19.1M |
| May 5, 2025 | -0.44 | -0.50 | N/A | $14.0M | $14.7M |
| Feb 28, 2025 | -0.44 | -0.53 | N/A | $19.0M | $4.5M |